Iron homeostasis in chronic inflammation

Kimmel P.L., 1998, Immunologic function and survival in hemodialysis patients, Kidney Int., 54, 236, 10.1046/j.1523-1755.1998.00981.x

Barany P., 1997, High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients, Am. J. Kidney Dis., 29, 565, 10.1016/S0272-6386(97)90339-5

Gunnell J., 1999, Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients, Am. J. Kidney Dis., 33, 63, 10.1016/S0272-6386(99)70259-3

Richardson D.R., 1997, The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells, Biochim. Biophys. Acta, 1331, 1, 10.1016/S0304-4157(96)00014-7

Andrews N.C., 1999, Disorders of iron metabolism, N. Engl. J. Med., 341, 1986, 10.1056/NEJM199912233412607

Sheth S., 2000, Genetic disorders affecting proteins of iron metabolism: clinical implications, Annu. Rev. Med., 51, 443, 10.1146/annurev.med.51.1.443

Mareschal J.C., 1980, The role of ceruloplasmin in Fe(III-transferrin formation in vitro, FEBS Lett., 110, 268, 10.1016/0014-5793(80)80089-5

Levy J.E., 1999, Transferrin receptor is necessary for development of erythrocytes and the nervous system, Nat. Genet., 21, 396, 10.1038/7727

Kawabata H., 1999, Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family, J. Biol. Chem., 274, 20826, 10.1074/jbc.274.30.20826

Gunshin H., 1997, Cloning and characterization of a mammalian proton-coupled metal-ion transporter, Nature, 388, 482, 10.1038/41343

Fleming M.D., 1997, Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene, Nat. Genet., 16, 383, 10.1038/ng0897-383

Harrison P.M., 1996, The ferritins: molecular properties, iron storage function and cellular regulation, Biochim. Biophys. Acta, 1275, 161, 10.1016/0005-2728(96)00022-9

Balla G., 1992, Ferritin: a cytoprotective antioxidant strategem of endothelium, J. Biol. Chem., 267, 18148, 10.1016/S0021-9258(19)37165-0

Balla J., 2000, Ferriporphyrins and endothelium: a 2-edged sword-promotion of oxidation and induction of cytoprotectants, Blood, 95, 3442, 10.1182/blood.V95.11.3442

Rouault T., 1997, Regulation of iron metabolism in eukaryotes, Curr. Top Cell Regul., 35, 1, 10.1016/S0070-2137(97)80001-5

Eisenstein R.S., 2000, Iron regulatory proteins and the molecular control of mammalian iron metabolism, Annu. Rev. Nutr., 20, 627, 10.1146/annurev.nutr.20.1.627

Kawabata H., 2001, Regulation of expression of murine transferrin receptor 2, Blood, 98, 1949, 10.1182/blood.V98.6.1949

Ferguson B.J., 1992, Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia, J. Lab. Clin. Med., 119, 385

Tessitore N., 2001, The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin, Nephrol. Dial. Transplant., 16, 1416, 10.1093/ndt/16.7.1416

Tenhunen R., 1968, The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase, Proc. Natl. Acad. Sci. USA, 61, 748, 10.1073/pnas.61.2.748

Maines MD, Kappas A: Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P-450 is not essential for this enzyme activity. Proc. Natl. Acad. Sci. USA 4293–4297 (1974)

Abraham N.G., 1988, Expression of heme oxygenase in hemopoiesis, Adv. Exp. Med. Biol., 241, 97, 10.1007/978-1-4684-5571-7_13

Baranano D.E., 2000, A mammalian iron ATPase induced by iron, J. Biol. Chem., 275, 15166, 10.1074/jbc.275.20.15166

Abboud S., 2000, A novel mammalian iron-regulated protein involved in intracellular iron metabolism, J. Biol. Chem., 275, 19906, 10.1074/jbc.M000713200

Conrad M.E., 2000, Iron absorption and transport — an update, Am. J. Hematol., 64, 287, 10.1002/1096-8652(200008)64:4<287::AID-AJH9>3.0.CO;2-L

Roy C.N., 2000, Iron homeostasis: new tales from the crypt, Blood, 96, 4020, 10.1182/blood.V96.13.4020

Donovan A., 2000, Positional cloning of zebrafish ferroportin 1 identifies a conserved vertebrate iron exporter, Nature, 403, 776, 10.1038/35001596

Vulpe C.D., 1999, Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse, Nat. Genet., 21, 195, 10.1038/5979

Alvarez-Hernandez X., 1989, Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor, Lab. Invest., 61, 319

Feelders R.A., 1998, Regulation of iron metabolism in the acute-phase response: interferon gamma and tumour necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients, Eur. J. Clin. Invest., 28, 520, 10.1046/j.1365-2362.1998.00323.x

Stam T.C., 2002, Regulation of ferritin: a specific role for interferon-alpha (IFN-alpha)? The acute phase response in patients treated with IFN-alpha-2b, Eur. J. Clin. Invest., 32, 79, 10.1046/j.1365-2362.2002.0320s1079.x

Drapier J.C., 1993, Biosynthesis of nitric oxide activates iron regulatory factor in macrophages, EMBO J., 12, 3643, 10.1002/j.1460-2075.1993.tb06038.x

Pantopoulos K., 1995, Nitric oxide signaling to iron-regulatory protein: direct control of ferritin mRNA translation and transferrin receptor mRNA stability in transfected fibroblasts, Proc. Natl. Acad. Sci. USA, 92, 1267, 10.1073/pnas.92.5.1267

Juckett M.B., 1996, Nitric oxide donors modulate ferritin and protect endothelium from oxidative injury, Free Radic. Biol. Med., 20, 63, 10.1016/0891-5849(95)02024-1

Bouton C., 1996, Modulation of iron regulatory protein functions. Further insights into the role of nitrogen- and oxygen-derived reactive species, J. Biol. Chem., 271, 2300, 10.1074/jbc.271.4.2300

Phillips J.D., 1996, Differential regulation of IRP1 and IRP2 by nitric oxide in rat hepatoma cells, Blood, 87, 2983, 10.1182/blood.V87.7.2983.bloodjournal8772983

Weiss G., 1997, Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13, J. Immunol., 158, 420, 10.4049/jimmunol.158.1.420

Recalcati S., 1998, Nitric oxide-mediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines: role of selective iron regulatory protein-2 downregulation, Blood, 91, 1059, 10.1182/blood.V91.3.1059

Bouton C., 1998, Converse modulation of IRP1 and IRP2 by immunological stimuli in murine RAW 264.7 macrophages, J. Biol. Chem., 273, 9403, 10.1074/jbc.273.16.9403

Kim S., 2000, Effects of interferon-gamma and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2, J. Biol. Chem., 275, 6220, 10.1074/jbc.275.9.6220

Kim S., 2002, Nitrogen monoxide-mediated control of ferritin synthesis: implications for macrophage iron homeostasis, Proc. Natl. Acad. Sci. USA, 99, 12214, 10.1073/pnas.192316099

Pantopoulos K., 1995, Rapid responses to oxidative stress mediated by iron regulatory protein, EMBO J., 14, 2917, 10.1002/j.1460-2075.1995.tb07291.x

Cairo G., 1996, Superoxide and hydrogen peroxide-dependent inhibition of iron regulatory protein activity: a protective stratagem against oxidative injury, FASEB J., 10, 1326, 10.1096/fasebj.10.11.8836047

Iwai K., 1998, Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins, Proc. Natl. Acad. Sci. USA, 95, 4924, 10.1073/pnas.95.9.4924

Miller L.L., 1991, Iron-independent induction of ferritin H chain by tumor necrosis factor, Proc. Natl. Acad. Sci. USA, 88, 4946, 10.1073/pnas.88.11.4946

Tsuji Y., 1991, Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts. Relationship to the induction of ferritin heavy chain, J. Biol. Chem., 266, 7257, 10.1016/S0021-9258(20)89638-0

Hershko C: Storage iron regulation. Prog. Hematol. 10, 105–148

Fillet G., 1989, Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation, Blood, 74, 844, 10.1182/blood.V74.2.844.844

Kooistra M.P., 1998, Iron absorption in erythropoietin-treated haemodialysis patients: Effects of iron availability, inflammation and aluminium, Nephrol. Dial. Transplant., 13, 82, 10.1093/ndt/13.1.82

Ganz T., 2003, Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation, Blood, 102, 783, 10.1182/blood-2003-03-0672

Kulaksiz H., 2004, Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia, Gut, 53, 735, 10.1136/gut.2003.022863

Taes Y.E., 2004, Prohepcidin accumulates in renal insufficiency, Clin. Chem. Lab. Med., 42, 387

1997, National Kidney Foundation-Dialysis Outcomes Quality Initiative, Am. J. Kidney Dis., 30, S192

1999, Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure, Nephrol. Dial. Transplant., 14, 1

Besarab A., 2000, Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients, J. Am. Soc. Nephrol., 11, 530, 10.1681/ASN.V113530

Braun J., 1996, Is zinc protoporphyrin an indicator of iron-deficient erythropoiesis in maintenance haemodialysis patients?, Nephrol. Dial. Transplant., 11, 492, 10.1093/ndt/11.3.492

Macdougall I.C., 1992, Detection of functional iron deficiency during erythropoietin treatment: a new approach, Br. Med. J., 304, 225, 10.1136/bmj.304.6821.225

Bovy C., 1999, Factors determining the percentage of hypochromic red blood cells in hemodialysis patients, Kidney Int., 56, 1113, 10.1046/j.1523-1755.1999.00627.x

Tessitore N., 2001, The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin, Nephrol. Dial. Transplant., 16, 1416, 10.1093/ndt/16.7.1416

Cullen P., 1999, Hypochromic red cells and reticulocyte haemglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis, Nephrol. Dial. Transplant., 14, 659, 10.1093/ndt/14.3.659

Fishbane S., 1997, Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients, Kidney Int., 52, 217, 10.1038/ki.1997.323

Mittman N., 1997, Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO, Am. J. Kidney Dis., 30, 912, 10.1016/S0272-6386(97)90104-9

Davis B.H., 1989, Flow cytometric reticulocyte quantification using thiazole orange provides clinically useful reticulocyte maturity index, Arch. Pathol. Lab. Med., 113, 684

Chuang C.L., 2003, Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients, Nephrol. Dial. Transplant., 18, 370, 10.1093/ndt/18.2.370

Means R.T., 1992, Progress in understanding the pathogenesis of the anemia of chronic disease, Blood, 80, 1639, 10.1182/blood.V80.7.1639.1639

Wang C.Q., 1995, Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development, J. Cell Physiol., 162, 134, 10.1002/jcp.1041620116

Allen D.A., 1999, Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: role of IFN-gamma and TNF-alpha, J. Investig. Med., 47, 204

Kato A., 2001, High blood soluble receptor p80 for tumour necrosis factor-alpha is associated with erythropoietin resistance in haemodialysis patients, Nephrol. Dial. Transplant., 16, 1838, 10.1093/ndt/16.9.1838

Maciejewski J.P., 1995, Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha, J. Clin. Invest., 96, 1085, 10.1172/JCI118094

Cooper A.C., 2003, Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy, J. Am. Soc. Nephrol., 14, 1776, 10.1097/01.ASN.0000071514.36428.61

Means R.T., 1991, Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin, Blood, 78, 2564, 10.1182/blood.V78.10.2564.2564